Vitamin D Dosing for Children
Maintenance Dosing (Prevention)
For routine supplementation in healthy children, give 400 IU daily for infants under 12 months and 600 IU daily for children and adolescents ages 1-18 years. 1
- Infants 0-12 months require 400 IU/day from all sources (diet plus supplements), as recommended by ESPGHAN, the American Academy of Pediatrics, and the Institute of Medicine 1
- Children and adolescents 1-18 years require 600 IU/day from all sources 1
- Preterm infants on parenteral nutrition need 200-1,000 IU/day (or 80-400 IU/kg/day) 1
Treatment Dosing for Deficiency
For children with documented vitamin D deficiency (25(OH)D <20 ng/mL), treat with 2,000 IU daily for 12 weeks or 50,000 IU every other week for 12 weeks, then transition to maintenance dosing. 1
Deficiency Severity-Based Approach:
- Severe deficiency (5-15 ng/mL): 4,000 IU/day orally for 12 weeks OR 50,000 IU every other week for 12 weeks 1
- Insufficiency (16-30 ng/mL): 2,000 IU daily OR 50,000 IU every 4 weeks 1
- Goal: Achieve 25(OH)D level above 20 ng/mL (50 nmol/L) 1
After Initial Treatment:
- Recheck 25(OH)D levels after the 12-week treatment period to confirm normalization 1
- Transition to maintenance therapy: 600 IU daily for children 1-18 years 1
- Monitor 25(OH)D levels every 6-12 months, especially during winter months 1
Formulation Choice
Use cholecalciferol (vitamin D3) rather than ergocalciferol (vitamin D2), as D3 has higher bioefficacy for treating deficiency. 1
Safety Thresholds - Upper Tolerable Limits
The Institute of Medicine established age-specific maximum safe doses to prevent toxicity 1:
- 0-6 months: 1,000 IU/day maximum
- 7-12 months: 1,500 IU/day maximum
- 1-3 years: 2,500 IU/day maximum
- 4-8 years: 3,000 IU/day maximum
- 9-18 years: 4,000 IU/day maximum
Prolonged daily intake up to 10,000 IU appears safe, but serum concentrations >375 nmol/L are associated with acute hypercalcemia and hyperphosphatemia 1
Concurrent Calcium Supplementation
Provide 250-500 mg/day of elemental calcium during vitamin D treatment to support bone mineralization and prevent hypocalcemia, particularly in children with low ionized calcium or elevated PTH at baseline. 1
This is critical because vitamin D enhances calcium absorption, and adequate calcium intake prevents secondary complications 1
Monitoring Strategy
Baseline Assessment:
- Measure 25(OH)D, calcium, phosphorus, alkaline phosphatase, and parathyroid hormone 1
- Assess for clinical manifestations of rickets at severe deficiency levels 1
Follow-up Monitoring:
- Recheck 25(OH)D after 12 weeks of treatment 1
- Once normalized, monitor every 6-12 months 1
- For children on long-term parenteral nutrition, monitor periodically and provide additional supplementation if 25(OH)D falls below 50 nmol/L 1
Special Populations Requiring Higher Doses
- Children with renal insufficiency: May need higher or more frequent supplementation 1
- Children on parenteral nutrition: Monitor for deficiency and provide additional supplementation if 25(OH)D <50 nmol/L 1
- Children with nephrotic syndrome: Monitor ionized calcium, 25-OH-D3, and PTH levels closely due to massive urinary losses of vitamin D-binding protein 1
- Children with malabsorption syndromes: Often require substantially higher doses 1
Critical Pitfalls to Avoid
- Do not use active vitamin D analogs (calcitriol) to treat nutritional vitamin D deficiency - these are reserved for specific conditions like chronic kidney disease 1
- Ensure adherence to the treatment regimen, as inconsistent supplementation leads to treatment failure 1
- Avoid excessive supplementation, though toxicity is rare at recommended doses 1
- Monitor calcium and phosphorus closely to avoid hypercalcemia, especially in children with CKD 1